moxifloxacin has been researched along with lenvatinib in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (lenvatinib) | Trials (lenvatinib) | Recent Studies (post-2010) (lenvatinib) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 975 | 112 | 946 |
| Protein | Taxonomy | moxifloxacin (IC50) | lenvatinib (IC50) |
|---|---|---|---|
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | 0.0162 | |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.039 | |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | 0.051 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.022 | |
| Kinesin-1 heavy chain | Homo sapiens (human) | 0.01 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.0052 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0035 | |
| Nuclear receptor coactivator 4 | Homo sapiens (human) | 0.01 | |
| Coiled-coil domain-containing protein 6 | Homo sapiens (human) | 0.01 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aluri, J; Darpo, B; Fan, J; Martinez, G; Ren, M; Shumaker, RC; Zhou, M | 1 |
1 trial(s) available for moxifloxacin and lenvatinib
| Article | Year |
|---|---|
Effect of lenvatinib (E7080) on the QTc interval: results from a thorough QT study in healthy volunteers.
Topics: Adult; Cross-Over Studies; Electrocardiography; Female; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Long QT Syndrome; Male; Moxifloxacin; Phenylurea Compounds; Quinolines; Young Adult | 2014 |